- Business
- WIN-Partners Co., Ltd. WIN-Partners Co., Ltd. (3183.T) operates as a holding company that, through its subsidiaries, distributes medical devices primarily to medical institutions across Japan. The company specializes in minimally invasive treatment products, particularly in cardiovascular applications, where it holds the largest market share for percutaneous coronary intervention (PCI) devices used in myocardial infarction and angina pectoris treatments; its core offerings include PTCA balloon catheters, drug-eluting stents (DES), and intravascular ultrasound (IVUS) catheters for PCI, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy defibrillators (CRTD), and ablation (ABL) catheters for the cardiac rhythm segment (CRS), stent grafts, transcatheter heart valves, and mechanical heart valves for the cardiac vascular segment (CVS), peripheral vascular stents, carotid artery stents, and embolic coils for percutaneous peripheral intervention (PPI) and neurovascular applications, as well as insulin pumps, continuous glucose monitoring (CGM) systems for the diabetes mellitus segment (DMS), and large-scale equipment such as computed tomography (CT) scanners. Approximately 67% of group sales derive from heart treatment-related products in fiscal year 2025, with expansion into non-cardiac areas including peripheral vascular disease, neurosurgery, and diabetes; operations focus on the Japanese market, serving hospitals and clinics through an extensive sales network headquartered at Kyobashi Edogrand in Tokyo, where the company was established on April 1, 2013, as a merger of WIN INTERNATIONAL and TESCO. Recent developments include TESCO's acquisition of TOSAY Medical, a major medical device distributor in Iwate Prefecture, in August 2022 to broaden regional coverage, alongside the company's transition to the Tokyo Stock Exchange Prime Market in April 2022; in June 2025, Office A Ltd. acquired over 5% of WIN-Partners' voting rights as a strategic long-term shareholder move equivalent to a tender offer. Subsidiaries such as TESCO, formerly including TESCO Akita (from Osawa Shoji acquisition in 2017) and MCI (from 2018 acquisition), support nationwide distribution of these specialized devices targeting cardiologists, vascular surgeons, and other minimally invasive specialists.